Treatment of perinfarction recurrent ventricular fibrillation by percutaneous pharmacological block of left stellate ganglion.
A patient suffering from an acute myocardial infarction presented on the seventh and eighth days of hospitalization recurrent episodes of ventricular fibrillation refractory to antiarrhythmic treatment. The life-threatening ventricular fibrillation was suppressed by percutaneous pharmacological block of the left stellate ganglion.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001340:Autonomic Nerve Block / Q000379:methods*; D003131:Combined Modality Therapy; D004562:Electrocardiography; D006801:Humans; D008012:Lidocaine; D008297:Male; D008619:Mepivacaine; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D012008:Recurrence; D013233:Stellate Ganglion / Q000187:drug effects; D014693:Ventricular Fibrillation / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D008012:Lidocaine; D008619:Mepivacaine